Pasithea Therapeutics Corp. (KTTAW)
Pasithea Therapeutics Announces Amendments to Clinical Study Protocol for Phase 1/1B NF1 Clinical Trial
Pasithea Therapeutics Announces Amendments to Clinical Study Protocol for Phase 1/1B NF1 Clinical Trial
Best Buy Canada Selects Perion as a Full-Stack Partner to Power its Retail DOOH Media Network
FORM 6-K- Company Presentation
Castle Biosciences TissueCypher® Test Surpasses 100,000 Orders, Advancing Precision Risk Assessment for Patients with Barretts Esophagus
Palladyne AI Deploys True Autonomy Drone-Swarming Software, SwarmOS™, During U.S. Army 4th Infantry Division Ivy Mass Exercise
Humana, CenterWell and National Hispanic Medical Association Announce 2026 Resident Physician Scholarship Program Recipients
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
SD Government announces Federal Aviation Administration STC approval for Gogo Galileo HDX installation on the Pilatus PC-12
Nephros Positions Ultrafiltration Technology as a Solution to Emerging Microplastic Risk in Water
HASI Prices $1 Billion of 5.950% Green Senior Unsecured Notes Due 2033